# FDA Inspection 1085858 - USC Reproductive Endocrinology and Infertility - March 21, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/usc-reproductive-endocrinology-and-infertility/5f882366-06c4-451c-8f18-bdecbdea3a4e
Source feed: FDA_Inspections

> FDA Inspection 1085858 for USC Reproductive Endocrinology and Infertility on March 21, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085858
- Company Name: USC Reproductive Endocrinology and Infertility
- Inspection Date: 2019-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1085858 - 2019-03-21](https://www.globalkeysolutions.net/records/fda_inspections/usc-reproductive-endocrinology-and-infertility/4b5cf526-a731-42be-ac68-682b338b559c)
- [FDA Inspection 986030 - 2016-06-15](https://www.globalkeysolutions.net/records/fda_inspections/usc-reproductive-endocrinology-and-infertility/91617eb5-bb83-43bc-9772-a85da68ff78d)
- [FDA Inspection 732291 - 2011-06-24](https://www.globalkeysolutions.net/records/fda_inspections/usc-reproductive-endocrinology-and-infertility/6724ff92-2a86-441d-9fbe-2a2aa233f312)

Company: https://www.globalkeysolutions.net/companies/usc-reproductive-endocrinology-and-infertility/1f152fa8-3c0b-4997-b214-9ef6504d8658

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d